US Stock MarketDetailed Quotes
APTO Aptose Biosciences
- 0.1750
- -0.0030-1.69%
Trading Nov 27 11:17 ET
3.42MMarket Cap-59P/E (TTM)
0.1900High0.1725Low696.52KVolume0.1900Open0.1780Pre Close127.41KTurnover4.79%Turnover RatioLossP/E (Static)19.52MShares2.907752wk High-0.37P/B2.54MFloat Cap0.130052wk Low--Dividend TTM14.54MShs Float1457.9988Historical High--Div YieldTTM9.83%Amplitude0.1300Historical Low0.1820Avg Price1Lot Size
Aptose Biosciences Key Stats
Quarterly+Annual
YOY
| (Q3)Sep 30, 2024 | (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q3)Sep 30, 2023 | (Q2)Jun 30, 2023 | (Q1)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q4)Dec 31, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow (Indirect Method) | ||||||||||
| Cash flow from continuing operating activities | 1.52%-10.38M | 57.21%-5.78M | -4.08%-11.76M | -37.96%-44.59M | -7.03%-9.26M | -50.97%-10.54M | -91.61%-13.5M | -17.18%-11.3M | 25.36%-32.32M | 46.08%-8.65M |
| Net income from continuing operations | 39.26%-6.95M | 48.67%-7.25M | 29.51%-9.64M | -22.44%-51.21M | -19.55%-11.96M | -17.08%-11.45M | -33.73%-14.13M | -19.12%-13.68M | 36.01%-41.82M | 58.89%-10M |
| Operating gains losses | ---- | --66K | --10K | ---- | ---- | ---- | ---- | ---- | 385.71%20K | 366.67%16K |
| Depreciation and amortization | -13.51%96K | -10.53%102K | -16.79%109K | -11.74%466K | 10.00%110K | -21.28%111K | -19.15%114K | -10.27%131K | -15.11%528K | -38.65%100K |
| Other non cash items | 171.43%15K | -84.48%9K | 40.00%28K | 45.36%-312K | 51.11%-329K | -125.61%-21K | 141.67%58K | 600.00%20K | -108.19%-571K | -109.70%-673K |
| Change In working capital | -1,678.92%-3.52M | 443.53%1.09M | -971.95%-3.08M | -34.91%2.81M | 137.06%2.5M | -85.28%223K | -112.34%-317K | 142.94%353K | 184.76%4.32M | 193.28%1.06M |
| -Change in prepaid assets | 1,017.24%324K | 80.06%560K | -3.91%246K | 50.87%261K | 73.72%-385K | -96.48%29K | -48.08%311K | 19.63%256K | 121.79%173K | -1.60%-1.47M |
| -Change in payables and accrued expense | -935.21%-2.97M | 207.39%567K | -2,511.54%-3.14M | -32.24%2.89M | 45.30%2.94M | -66.16%355K | -124.86%-528K | 114.05%130K | 195.98%4.27M | 2,061.17%2.02M |
| -Change in other current assets | -1,645.45%-768K | 247.27%81K | -177.89%-74K | -176.61%-343K | -480.90%-339K | 80.44%-44K | -175.00%-55K | 196.88%95K | -3,000.00%-124K | 4,550.00%89K |
| -Change in other current liabilities | 4.27%-112K | -164.44%-119K | 10.16%-115K | ---- | ---- | 12.69%-117K | 66.42%-45K | 10.49%-128K | ---- | ---- |
| Cash from discontinued investing activities | ||||||||||
| Operating cash flow | 1.52%-10.38M | 57.21%-5.78M | -4.08%-11.76M | -37.96%-44.59M | -7.03%-9.26M | -50.97%-10.54M | -91.61%-13.5M | -17.18%-11.3M | 25.36%-32.32M | 46.08%-8.65M |
| Investing cash flow | ||||||||||
| Cash flow from continuing investing activities | 0 | 202.50%2.01M | 32.74%-1.99M | -66.87%9.96M | -88.97%1.94M | 355.08%12.95M | -119.47%-1.96M | -139.44%-2.96M | 185.40%30.07M | 187.82%17.57M |
| Net PPE purchase and sale | --0 | 158.62%17K | --1K | -20.83%-29K | --0 | --0 | -20.83%-29K | --0 | 88.68%-24K | --0 |
| Net investment purchase and sale | --0 | 203.16%1.99M | 32.70%-1.99M | -66.80%9.99M | -88.97%1.94M | 355.08%12.95M | -119.14%-1.93M | -139.44%-2.96M | 185.98%30.09M | 187.88%17.57M |
| Cash from discontinued investing activities | ||||||||||
| Investing cash flow | --0 | 202.50%2.01M | 32.74%-1.99M | -66.87%9.96M | -88.97%1.94M | 355.08%12.95M | -119.47%-1.96M | -139.44%-2.96M | 185.40%30.07M | 187.82%17.57M |
| Financing cash flow | ||||||||||
| Cash flow from continuing financing activities | 104.16%10.01M | 330.62%4.75M | 23,594.00%11.85M | 5,856.90%6.91M | 1,574.51%854K | 23,242.86%4.9M | 3,706.90%1.1M | 233.33%50K | -48.67%116K | -22.73%51K |
| Net issuance payments of debt | --10M | ---- | ---- | ---- | ---- | --0 | ---- | ---- | ---- | ---- |
| Net common stock issuance | --0 | 344.63%4.93M | 34,691.18%11.83M | 6,712.87%6.88M | 1,652.94%894K | 22,966.67%4.84M | 3,724.14%1.11M | --34K | 180.56%101K | 41.67%51K |
| Proceeds from stock option exercised by employees | -38.46%8K | --0 | 12.50%18K | 93.33%29K | --0 | --13K | --0 | 6.67%16K | -92.11%15K | --0 |
| Net other financing activities | ---- | -3,440.00%-177K | ---- | ---- | ---- | --45K | ---5K | ---- | ---- | ---- |
| Cash from discontinued financing activities | ||||||||||
| Financing cash flow | 104.16%10.01M | 330.62%4.75M | 23,594.00%11.85M | 5,856.90%6.91M | 1,574.51%854K | 23,242.86%4.9M | 3,706.90%1.1M | 233.33%50K | -48.67%116K | -22.73%51K |
| Net cash flow | ||||||||||
| Beginning cash position | -0.83%8.33M | -67.73%7.35M | -74.97%9.25M | -5.48%36.97M | -43.84%15.72M | -79.02%8.4M | -38.47%22.76M | -5.48%36.97M | -66.68%39.11M | -62.73%27.99M |
| Current changes in cash | -105.03%-368K | 106.86%985K | 86.58%-1.91M | -1,195.33%-27.72M | -172.07%-6.47M | 160.81%7.32M | -571.10%-14.36M | -568.80%-14.21M | 97.27%-2.14M | 124.93%8.97M |
| Effect of exchange rate changes | --0 | 66.67%-1K | -75.00%1K | 150.00%2K | -116.67%-1K | 114.29%1K | 40.00%-3K | 100.00%4K | -157.14%-4K | -14.29%6K |
| End cash Position | -49.35%7.96M | -0.83%8.33M | -67.73%7.35M | -74.97%9.25M | -74.97%9.25M | -43.84%15.72M | -79.02%8.4M | -38.47%22.76M | -5.48%36.97M | -5.48%36.97M |
| Free cash flow | 1.52%-10.38M | 57.30%-5.78M | -4.08%-11.76M | -37.94%-44.62M | -7.03%-9.26M | -50.97%-10.54M | -91.37%-13.53M | -17.18%-11.3M | 25.67%-32.35M | 46.13%-8.65M |
| Currency Unit | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | -- | -- | -- | Unqualified Opinion | -- | -- | -- | -- | Unqualified Opinion with Explanatory Notes | -- |
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
% Chg
No Data